Can-Fite Biopharma Ltd. current report, Q3 FY2018

Full document

Business Context and Reporting Period

This Form 6-K filing by Can-Fite Biopharma Ltd. is dated August 8, 2018. The report addresses the re-issuance of consolidated financial statements for the fiscal year ended December 31, 2017. The primary purpose of this filing is to reflect a change in the Company's functional and presentation currency from the New Israeli Shekel (NIS) to the U.S. dollar, effective January 1, 2018.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it serves as a cover document incorporating re-stated financial exhibits (Exhibit 99.1) and an Operating and Financial Review (Exhibit 99.2) prepared in accordance with International Financial Reporting Standards (IFRS) and reported in U.S. dollars.

Material Changes Versus Prior Period

  • Currency Change: The Company changed its functional and presentation currency from NIS to U.S. dollars based on management's assessment that the U.S. dollar is the primary currency of its economic environment.
  • Restatement: The attached financial statements replace the previously issued statements (filed in the March 28, 2018 Form 20-F) which were reported in NIS.

Guidance, Outlook, and Risks

The filing text itself does not contain specific guidance, outlook, or risk commentary. It references an attached "Operating and Financial Review and Prospects" (Exhibit 99.2) which contains the relevant management discussion. The filing notes that the re-issued documents are incorporated by reference into the Company's Registration Statements on Form F-3.

Investor Verification Checklist

  • Verify the specific financial figures in the re-issued Exhibit 99.1 (Consolidated Financial Statements) to compare U.S. dollar amounts against the previously reported NIS figures.
  • Review Exhibit 99.2 for updated management commentary on prospects and risks following the currency transition.
  • Confirm the impact of the currency change on historical comparability for the year ended December 31, 2017.